CD274 and Miyoshi myopathy: Nowadays, ipilimumab is not used as a standalone treatment in many patients, thus first we will have to validate if SCFA are also associated to clinical outcomes in patients treated with anti-PD-1/PD-L1 since Faecalibacterium was also associated to clinical outcomes in MM patients7.